Navigation Links
Trends in prescription medication sharing among reproductive-aged women
Date:8/25/2008

New Rochelle, NY, August 25, 2008Borrowing and sharing of prescription medications is a serious medical and public health concern. A survey of nearly 7,500 women of reproductive age found that this is common practice among more than one-third of this population, according to a report published online ahead of print in Journal of Women's Health, a peer-reviewed journal published by Mary Ann Liebert, Inc. The paper is available free online at http://www.liebertonline.com/doi/pdfplus/10.1089/jwh.2007.0769

A study designed to describe patterns of prescription medication borrowing and sharing among various groups of adults revealed that women of reproductive age (18-44 years) are more likely to report this practice (36.5%) than are other aged women (19.5%). In the overall survey of more than 25,000 women and men, 28.8% of women and 26.5% of men reported ever borrowing or sharing prescription medications.

In a paper entitled "Prescription Medication Borrowing and Sharing among Women of Reproductive Age," Emily Petersen, Sonja Rasmussen, Katherine Daniel, Mahsa Yazdy, and Margaret Honein, from the Centers for Disease Control and Prevention (CDC, Atlanta, Georgia) and Oak Ridge Institute for Science & Education (Oak Ridge, Tennessee), report that allergy medications (43.8%) and pain medications (42.6%) were the types of drugs most commonly borrowed or shared by reproductive-aged women.

The authors emphasize some of the risks involved in using another person's prescription drugs, including unanticipated side effects, complications of incorrect use, drug-drug interactions, antibiotic resistance, and risk of addiction. Of great importance for reproductive-aged women is the risk of teratogenic effects on a developing embryo or fetus if the women were to become pregnant while taking the medication.

"This study confirms what many health care provider
'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Page: 1 2

Related biology news :

1. Dry Tortugas show positive trends: Protected area slowly rebounding
2. Study identifies trends of vitamin B6 status in US population sample
3. Scientists test device to track medication adherence in patients with HIV/AIDS
4. Genetic variant mimics effect of heart failure medications
5. Study of successful drug targets could hasten development of new medications
6. Selective restraints and reduced medication could reduce nursing home falls says 4-year study
7. Device prevents potential errors in childrens medications
8. Time-sharing tropical birds key to evolutionary mystery
9. BIO-key(R) Announces Contracts for New Criminal Justice Data Sharing Solution
10. Heavy metal link to mutations, low growth and fertility among crustaceans in Sydney Harbor tributary
11. Peers important for nutrition education among Latinos

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., NEW YORK (November 24, 2009) -- T...oday a report revealing that the last remaining po...gnificantly due to the rising tide of poaching and... will help inform Russian officials of what needs ... world,s biggest cat. , The report ...
(Date:11/23/2009)... CINCINNATINew research presents strong evidence t...e to both outdoor traffic-related pollution and in...s than one or the other exposure alone. , Envi...incinnati (UC) College of Medicine have shown that...elated particles and indoor endotoxin during early...
(Date:11/23/2009)... IRVINE, Calif. -- More than 160 participants gath...demies Keck FUTURES INITIATIVE conference. This ye...scientists, engineers, and medical researchers to ...sues surrounding the emerging field of synthetic b...lar biology at Princeton University and this year,...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 1PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 2PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 3PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 4Cardium Regains Listing Compliance with NYSE Amex 13207 1Cardium Regains Listing Compliance with NYSE Amex 13207 2Cardium Regains Listing Compliance with NYSE Amex 13207 3Insmed Provides Update on Supply of IPLEX 28TM 29 52763 1Insmed Provides Update on Supply of IPLEX 28TM 29 52763 2Insmed Provides Update on Supply of IPLEX 28TM 29 52763 3
... between Pakistan and India using their current ar...gering human health problems and wreaking environm...study led by the University of Colorado at Boulder... war between the two countries involving 50 Hirosh... massive urban fires and loft as much as 5 million...
...ped at NJIT for early diagnosis of Alzheimers, Par...d title at a recent New Jersey Technology Council ...ogram, the Enterprise Development Center, NeuroTra...ed most likely to succeed. The event drew 60 young... , NeuroTrax develops and markets diagnostic prod...
...n the womb, researchers from Tel Aviv University b...male twin can compromise the health of his twin si...ly published in the journal Pediatrics, the resear...h as respiratory distress syndrome, found in pre-t...e womb with a boy twin lost the respiratory health...
Other Biology News:Regional nuclear conflict would create near-global ozone hole, says CU-Boulder study 2Regional nuclear conflict would create near-global ozone hole, says CU-Boulder study 3NJIT start-up company NeuroTrax named best in show 2War between the sexes begins before twins' birth, TAU researchers say 2
(Date:11/24/2009)...orpatientswithadvanced-stage,orrecurrentendometria...Call/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(t...donendocrinetherapyandoncology,todayannouncedposit...toxicpeptideconjugate,AEZS-108(formerlyAN-152),inp...apersonalizedhealthcareapproach,thestudyselectedpa...
(Date:11/24/2009)...re-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )to...eChairman,willpresentatthe21stAnnualPiperJaffrayHe...,2009at10:00a.m.ET. ,, Toaccesstheliveandsubseq...estorRelationssectionofGenomicHealth,swebsiteat ht...ewebsiteatleast15minutespriortothebeginningofthepr...
(Date:11/24/2009)...l/--CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CTIC)m...lthCareConference.TheconferencewillbeheldDecember1...entonTuesday,December1at11:00a.m.EasternTimeinHolm...willbeavailableat www.celltherapeutics.com ,anditw...ffrayHealthCareConference,NewYorkPalaceHotel,Holme...
(Date:11/23/2009)...arbon layer in which the carbon atoms are arranged...arbon nanotubes are rolled-up sheets of graphene, ...Graphene boasts some very special characteristics ...mal conductor, and reconciles such conflicting qua...graphene is impermeable to gases, which makes it i...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2Polymer with honeycomb structure 2
...s Pharma, the,Danish biopharmaceutical company dev...at Keith McCullagh, President and Chief Executive,...pany and its goals for,2008 at the Biotechnology I...Conference in New York, today, Monday February 11t...ral European Time). The conference is,being held a...
...28, The Royal,Marsden Hospital (Sutton, Surrey, UK...lated Arc Therapy (VMAT)* treatment in the world u...e the treatment, the hospital,used its existing El...n,linear accelerator control system., (Logo: htt...GO ), VMAT takes Intensity Modulated Radiation T...
...0 Doses of the CDC,s National Strategic...OLIS, Feb. 11 Sentry Logistic Solutions,announced...ention (CDC),signed a contract to outsource storag...ve of the influenza virus vaccine. Sentry will war...ses from its pharmaceutical cold,chain logistics c...
Other Biology Technology:Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008 2Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital 2The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions 2The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions 3
Anti-Xanthine Oxidase, Buttermilk Polyclonal Antibody, Unconjugated from CHEMICON
Anti-JNK1 / SAPK Antibody, Unconjugated from Cell Sciences
Acrylamide, Molecular Biology Grade from Research Organics, Inc.
UltraClean Low Melt Agarose from Mo Bio Laboratories, Inc.
Biology Products: